IP Verse

R Pharm competitive analysis

Latest oppositions filed by R Pharm

Explore patent oppositions filed by R Pharm against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 17, 2026

Patent Number	Title	Applicant	Opposition Date
EP3519049	Safe And Effective Method Of Treating Psoriasis With Anti-Il23 Specific Antibody	JANSSEN BIOTECH	Sep 1, 2026
EP4019041	Toxicity Management For Anti-Tumor Activity Of Cars	THE CHILDRENS HOSPITAL OF PHILADELPHIA	Sep 28, 2023
EP2578231	Antitumor T Cell Response Enhancer	CHUGAI SEIYAKU KABUSHIKI KAISHA	Jul 25, 2023
EP3433276	Early Intervention Methods To Prevent Or Ameliorate Toxicity	SEATTLE CHILDRENS HOSPITAL DBA SEATTLE CHILDRENS RESEARCH INSTITUTE	Sep 20, 2022
EP2872171	Toxicity Management For Anti-Tumor Activity Of Cars	THE CHILDRENS HOSPITAL OF PHILADELPHIA	Oct 6, 2021
EP3338794	Toxicity Management For Anti-Tumor Activity Of Cars	THE CHILDRENS HOSPITAL OF PHILADELPHIA	Nov 25, 2020
EP2832350	Method For Producing Disintegrating Particulate Composition Comprising Acid-Type Carboxymethylcellulose, Disintegrating Particulate Composition Comprising Acid-Type Carboxymethylcellulose, And Orally Disintegrating Tablet Including Disintegrating Particulate Composition Comprising Acid-Type Carboxymethylcellulose	DAICEL	Apr 16, 2020
EP3092226	Indazole Compounds As Irak4 Inhibitors	AURIGENE DISCOVERY	Dec 11, 2019
EP2926142	Identification Of Patients In Need Of Pd-L1 Inhibitor Cotherapy	F HOFFMANN LA ROCHE	Aug 7, 2019
EP2794635	Ion Exchange Membrane Chromatography	F HOFFMANN LA ROCHE	Jun 12, 2019

Latest patents of R Pharm opposed by its competitors

Explore R Pharm's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 17, 2026

Patent Number	Publication Date	Title	Total Oppositions
EP2527371	Aug 17, 2016	Method For The Treatment Of Glomerulonephritis	1

Latest PTAB cases involving R Pharm

Discover the latest PTAB cases involving R Pharm, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing R Pharm with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 17, 2026

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
CELATOR PHARMACEUTICALS	-	7	-	-
D YOUNG	35	-	-	-
GENERICS UK	319	-	-	-
SANDOZ	149	26	19	-